SCHEMBL7702517

SCHEMBL7702517

c1cc(OCCCN2CCNCC2)cc(-c2n[nH]c3c2Cc2ccccc2-3)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.57
CHEK1 O14757 11/20 0.53
MARK3 P27448 3/20 0.48
MARK2 Q7KZI7 3/20 0.48
AURKB Q96GD4 3/20 0.48
CDK2 P24941 2/20 0.48
RET P07949 2/20 0.48
RPS6KA3 P51812 2/20 0.48
MELK Q14680 2/20 0.48
BRSK1 Q8TDC3 2/20 0.48
PDGFRA P16234 1/20 0.48
FLT4 P35916 1/20 0.48
TYRO3 Q06418 1/20 0.48
CAMK2G Q13555 1/20 0.48
CAMK2D Q13557 1/20 0.48
MAP4K5 Q9Y4K4 1/20 0.48
FLT3 P36888 2/20 0.46
AURKA O14965 1/20 0.46
CHEK2 O96017 1/20 0.46
LCK P06239 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702307 0.96 KDR (0.54) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7172093 0.95 KDR (0.58) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7700924 0.92 KDR (0.67) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7703072 0.92 KDR (0.55) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7703663 0.91 CHEK1 (0.62) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7703429 0.90 CHEK1 (0.63) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7702402 0.89 KDR (0.63) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7147004 0.87 KDR (0.68) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7147015 0.87 KDR (0.59) KDRCHEK1MARK3MARK2AURKB
SCHEMBL7699601 0.85 CHEK1 (0.62) KDRCHEK1MARK3MARK2AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed